Latest News and Press Releases

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) and...

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Dow Inc.  (“Dow” or the “Company”) (NYSE: DOW) and certain officers.   The...

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Vesalius Longevity Labs, the first soon-to-be publicly traded company dedicated exclusively to longevity science, today announced a landmark partnership...

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc.  (“Jasper” or the “Company”) (NASDAQ: JSPR) and...

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Dow Inc. (“Dow” or the “Company”) (NYSE: DOW) and certain officers. The class...

NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc.  (“Jasper” or the “Company”) (NASDAQ: JSPR) and...

NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Dow Inc. (“Dow” or the “Company”) (NYSE: DOW) and certain officers. The class...

SAN DIEGO, Oct. 11, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23,...

Ottawa, Oct. 08, 2025 (GLOBE NEWSWIRE) -- 503A U.S. Compounding Pharmacies Market Growth The global 503A U.S. compounding pharmacies market size was valued at USD 4.47billion in 2024 and is...

SAN DIEGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23,...